GERMANTOWN, Md. & VENLO, Netherlands–(BUSINESS WIRE)—- $QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstream infection portfolio following clearance of a new panel by the U.S. Food and Drug Administration (FDA). The new panel detects gram-negative bacteria and antibiotic resistance markers in about one hour, complementing the recently FDA-cleared QIAstat-Dx panel for gram-positive bacteria and fungi.
Tag: Business Wire
SINGAPORE–(BUSINESS WIRE)–Antom today announced a series of key appointments for its operations in Southeast Asia to better serve merchants with full-stack AI-native solutions.
SINGAPORE–(BUSINESS WIRE)–Antom today announced a series of key appointments for its operations in Southeast Asia to better serve merchants with full-stack AI-native solutions.
PLEASANTON, Kalifornien–(BUSINESS WIRE)–OPM Biosciences, ein Anbieter von Zellkulturmedien und Bioprozesslösungen, gab heute zwei neue Angebote bekannt, mit denen die OPM-CHO™-Plattform auf die Entwicklung und Herstellung von Biosimilars ausgeweitet wird: den „Biosimilar Media Optimization Service“ und die „Sureness™ Biosimilar Platform“. Zellkulturmedien können das Zellwachstum, die Produktivität und kritische Qualitätsmerkmale (CQAs) erheblich beeinflussen, wodurch die Medienstrategie zu ei
PLEASANTON, Kalifornien–(BUSINESS WIRE)–OPM Biosciences, ein Anbieter von Zellkulturmedien und Bioprozesslösungen, gab heute zwei neue Angebote bekannt, mit denen die OPM-CHO™-Plattform auf die Entwicklung und Herstellung von Biosimilars ausgeweitet wird: den „Biosimilar Media Optimization Service“ und die „Sureness™ Biosimilar Platform“. Zellkulturmedien können das Zellwachstum, die Produktivität und kritische Qualitätsmerkmale (CQAs) erheblich beeinflussen, wodurch die Medienstrategie zu ei
PLEASANTON, Calif.–(BUSINESS WIRE)–OPM Biosciences, een bedrijf gespecialiseerd in celkweekmedia en oplossingen voor bioprocessen, kondigde vandaag twee nieuwe aanbiedingen aan die zijn OPM-CHO™-platform naar ontwikkeling en productie van biosimilars uitbreiden: de Biosimilar Media Optimization Service en het Sureness™ Biosimilar Platform. Celkweekmedia kunnen celgroei, productiviteit en CQA’s (critical quality attributes) aanzienlijk beïnvloeden, waardoor mediastrategie een belangrijke compo
LOS ANGELES, Calif.–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (“EAI”) ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia, originally scheduled for September 27, has been rescheduled for September 28, one day later than planned. Additionally, the Company has invited 10 global partners to participate in its FF EAI “Built in
LOS ANGELES, Calif.–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (“EAI”) ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia, originally scheduled for September 27, has been rescheduled for September 28, one day later than planned. Additionally, the Company has invited 10 global partners to participate in its FF EAI “Built in
LOS ANGELES, Calif.–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (“EAI”) ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia, originally scheduled for September 27, has been rescheduled for September 28, one day later than planned. Additionally, the Company has invited 10 global partners to participate in its FF EAI “Built in
LOS ANGELES, Calif.–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (“EAI”) ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia, originally scheduled for September 27, has been rescheduled for September 28, one day later than planned. Additionally, the Company has invited 10 global partners to participate in its FF EAI “Built in